A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer
Conditions: Gastric Cancer/Adenocarcinoma of Esophagogastric Junction Interventions: Drug: Fruquintinib 、Nivolumab、Sintilimab、Oxaliplatin、Teysuno、Capecitabine Sponsors: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Research | Study | Xeloda